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H E A L T H  A N D  M E D I C I N E
Sustained oxygenation accelerates diabetic wound 
healing by promoting epithelialization and  
angiogenesis and decreasing inflammation
Ya Guan1†, Hong Niu1†, Zhongting Liu1, Yu Dang1, Jie Shen2, Mohamed Zayed3,  
Liang Ma4, Jianjun Guan1*
Nonhealing diabetic wounds are common complications for diabetic patients. Because chronic hypoxia prominently 
delays wound healing, sustained oxygenation to alleviate hypoxia is hypothesized to promote diabetic wound 
healing. However, sustained oxygenation cannot be achieved by current clinical approaches, including hyperbaric 
oxygen therapy. Here, we present a sustained oxygenation system consisting of oxygen-release microspheres 
and a reactive oxygen species (ROS)–scavenging hydrogel. The hydrogel captures the naturally elevated ROS in 
diabetic wounds, which may be further elevated by the oxygen released from the administered microspheres. The 
sustained release of oxygen augmented the survival and migration of keratinocytes and dermal fibroblasts, 
promoted angiogenic growth factor expression and angiogenesis in diabetic wounds, and decreased the 
proinflammatory cytokine expression. These effects significantly increased the wound closure rate. Our findings 
demonstrate that sustained oxygenation alone, without using drugs, can heal diabetic wounds.
INTRODUCTION
Diabetes is a chronic metabolic disorder affecting 34.2 million 
people across the United States (1). One of the common complica-
tions of diabetes is diabetic foot ulcers (DFUs). Roughly 25% of 
diabetic patients experience DFU (2), which causes prolonged pain, 
decreased vitality, and possibly the need for foot amputation. 
Conservative medical care for DFU, such as wound off-loading, wound 
debridement, and infection control (3), has inconsistent outcomes 
and is associated with undesired side effects (3, 4). Stable and safe 
treatments for chronic, nonhealing diabetic wounds could benefit 
millions of people.
Cutaneous diabetic wound healing is a complex process with three 
overlapping phases: inflammation, proliferation, and remodeling (5). 
Immediately after the precipitating injury, impaired vasculature 
impedes oxygen delivery to the wound, creating a hypoxic environment 
around the wound (5–7). This hypoxia is exacerbated by the recruit-
ment of inflammatory cells with high oxygen consumption (8, 9). 
Although acute hypoxia promotes cell proliferation and initiates 
tissue repair, long-term oxygen deprivation in chronic wounds impairs 
the healing process via inhibition of angiogenesis, reepithelialization, 
and extracellular matrix (ECM) synthesis (10). Thus, enhanced wound 
tissue oxygenation is key to chronic wound healing.
In the past few decades, diabetic wound healing has been clinically 
facilitated by oxygenation, particularly hyperbaric oxygen therapy 
(HBOT) (11). HBOT delivers 100% oxygen at 2 to 3 atm for 1 to 
2 hours per treatment to patients with DFU. In some cases, HBOT 
promoted diabetic wound healing after 40 or more treatments 
(12, 13), while in other studies, it did not show beneficial effects 
(11, 14). Overall, the therapeutic efficacy of HBOT is widely considered 
to be inconsistent and unsatisfactory (15, 16). This poor performance 
mainly results from HBOT’s inability to continuously provide sufficient 
oxygen to the wounds because the oxygen content in the poorly 
vascularized wounds decreases quickly following the treatment (17). 
Moreover, as a systemic oxygen delivery strategy, HBOT may create 
risks of tissue hyperoxia, such as oxygen toxicity seizure (17, 18).
Several previous reports have developed oxygen-generating 
systems that are implanted locally to increase the oxygen concentration 
in wound beds to address the limitations of systemic oxygenation. 
These oxygen-generating systems were based on H2O2 (hydrogen 
peroxide) (19), calcium peroxide (20, 21), and perfluorocarbon (22). The 
localized oxygenation can avoid systemic hyperoxia while accelerating 
chronic wound healing. However, these oxygenation systems typically 
release oxygen for only 3 to 6 days (20, 22), which is not long enough for 
diabetic wound healing. In addition, these systems cannot quickly release 
sufficient oxygen to relieve hypoxia (20, 21). Oxygen is required for 
important events, including angiogenesis, granulation, reepithelialization, 
and ECM synthesis, that often take 2 weeks or longer (6, 23, 24). Hence, 
it is critical to develop oxygen-generating systems that continuously 
oxygenate the wound bed for long periods to accelerate healing.
Here, we present an oxygen-generating system based on oxygen- 
release microspheres (ORMs) and an injectable, fast-gelling, and 
reactive oxygen species (ROS)–scavenging hydrogel (ROSS gel). The 
microspheres quickly release enough oxygen to support cell survival 
under hypoxia and sustain the release of oxygen for at least 2 weeks. 
Unlike most current oxygen-generating systems that first release toxic 
H2O2 into the tissue environment and then rely on its decomposition 
to release oxygen, the designed ORMs directly release oxygen. The 
injectable and fast-gelling hydrogel is used as a carrier to deliver the 
microspheres into wounds and quickly immobilize them there, with 
a high tissue retention rate. The hydrogel has a relatively high water 
content, enabling it to maintain a moist environment surrounding the 
wound (25). Because it can also scavenge ROS, the oxygen-generating 
system can capture excessive ROS in diabetic wounds. While ROS 
play a crucial role in regulating biological and physiological processes, 
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elevated ROS in diabetic wounds can damage cells (26, 27). In this 
study, we assessed the therapeutic efficacy of the oxygen-generating 
system in promoting wound closure. We also elucidated the underlying 
mechanisms of how sustained oxygen release promotes diabetic 
wound healing. While previous studies have shown that short-term 
oxygen release facilitated wound closure, the underlying mechanisms 
were not fully clear and were mainly attributed to wound angiogenesis 
(28). We comprehensively evaluated the effect of sustained oxygen 
release on skin cell survival, migration, and paracrine effects; intra-
cellular oxygen content; prosurvival pathways; tissue angiogenesis; 
and tissue inflammation and oxidative stress.
RESULTS
Microspheres released molecular oxygen continuously
The ORMs had a core-shell structure (Fig. 1A), in which the core 
was a stable polyvinylpyrrolidone (PVP)/H2O2 complex. The shell 
was bioeliminable and bioconjugatable poly(N- isopropylacrylamide- 
co-2-hydroxyethyl methacrylate- co-acrylate- oligolactide-co-N-
acryloxysuccinimide) [poly(NIPAAm-co-HEMA- co-AOLA-co-NAS)] 
(fig. S1). The microspheres had a diameter of ~5 m (Fig. 1B). The 
core-shell structure was confirmed by fluorescent images (Fig. 1C). 
The shell of the microspheres was conjugated with catalase to timely 
convert the H2O2 in the released PVP/H2O2 into molecular oxygen 
and keep H2O2 from exiting the microspheres and causing toxicity 
concerns. A layer of catalase was conjugated on the shell, as evidenced 
by the fluorescence signal of fluorescein isothiocyanate (FITC)–
labeled catalase (Fig. 1D).
To determine the oxygen-release kinetics, we used an oxygen- 
sensitive luminophore, Ru(Ph2phen3)Cl2, whose fluorescence intensity 
is linearly proportional to the oxygen content (29, 30). The ORMs 
were able to continuously release oxygen during the 2-week experi-
mental period (Fig. 1E). The oxygen level reached above 5% after 
2 days of release, and it was maintained above 10% from days 3 to 14. 
After the 2-week study period, the release medium contained less 
than 10 M H2O2, as measured by a quantitative peroxide assay kit. 
This concentration will not cause cell apoptosis (31).
Continuous oxygenation of skin cells by released oxygen 
promoted skin cell survival, migration and paracrine effects, 
and endothelial lumen formation under hypoxia in vitro
In diabetic wounds, hypoxia is a major factor compromising cell 
survival and migration, leading to slow wound healing (6, 30, 32). 
To evaluate whether oxygen released from ORMs was able to improve 
cell survival under hypoxia, we incubated human keratinocytes 
(HaCaT cells), human dermal fibroblasts (HDFs), and human arte-
rial endothelial cells (HAECs) with the ORMs under 1% oxygen. All 
three cell types exhibited a significantly higher double-stranded DNA 
(dsDNA; characteristic of live cells) content than the corresponding 
control groups without ORMs (P < 0.001 for HaCaT cells and HAEC 
and P < 0.01 for HDF; Fig. 1, F to H). These results demonstrate 
that the released oxygen effectively increased skin cell survival 
under hypoxia. One of the concerns of oxygen treatment is the 
overproduction of ROS. To characterize ROS expression in the three 
cell types, we used an ROS-sensitive dye, CM-H2DCFDA, to stain 
the cells cultured under normoxia, hypoxia (1% oxygen), and hypoxia 
with the addition of ORMs (hypoxia/ORM group). The released 
oxygen in the hypoxia/ORM group substantially increased the ROS 
level in the three cell types compared to the hypoxia group (Fig. 1, I to K, 
and figs. S2 to S4). However, the ROS level was similar to the 
normoxia group (P > 0.05 for all cell types). These results, together with 
dsDNA results, show that the released oxygen did not overproduce 
ROS and induce cell apoptosis.
To determine whether the released oxygen could increase the 
migration of keratinocytes and dermal fibroblasts, a scratch assay 
was performed. After 48 hours of incubation under 1% oxygen, the 
migration rates of HaCaT cells and HDFs were significantly higher 
in the ORM groups than in the control groups without ORMs 
(P < 0.001; Fig. 1, L, M, O, and P). These results demonstrate that 
the released oxygen promoted skin cell migration under hypoxia.
We further elucidated the effect of released oxygen on skin cell 
expression of angiogenic growth factors under hypoxic conditions. 
For HaCaT cells, treatment with ORMs significantly increased the 
expression of vascular endothelial growth factor-A (VEGFA; P < 0.05) 
and basic fibroblast growth factor (FGF2; P < 0.001) (Fig. 1N). For 
HDFs, the released oxygen significantly augmented the expression 
of platelet-derived growth factor-B (PDGFB; P < 0.001) and FGF2 
(P  <  0.001) (Fig.  1Q). These growth factors play critical roles in 
reepithelialization and angiogenesis during cutaneous wound healing 
(33–36). It remains to be investigated whether the up-regulation of 
these growth factors is associated with a signaling cascade, which 
can be activated by the released oxygen.
In chronic wounds, the hypoxic environment impairs angiogenesis, 
resulting in delayed wound healing (37). To evaluate the potential 
of released oxygen in promoting angiogenesis under hypoxia, we 
conducted an in vitro endothelial tube formation assay (Fig. 1R). 
The ORM was injected into three-dimensional (3D) collagen 
constructs seeded with HAECs. Following 16 hours of culture under 
1% oxygen, the HAECs assembled with a significantly greater number 
of lumens, exhibiting an ~2.5-fold increase in lumen density than 
the control group (P < 0.01; Fig. 1, S and T).
Continuous oxygenation by released oxygen elevated 
intracellular oxygen content and adenosine triphosphate 
content and activated extracellular signal–regulated kinase 
1/2 and heme oxygenase 1 signaling
To explore how continuous oxygenation by released oxygen increased 
skin cell survival and migration, we used electron paramagnetic 
resonance (EPR) to measure the intracellular oxygen content in 
HaCaT cells (Fig. 2A). After 24 hours of treatment with ORMs 
under 1% oxygen, the intracellular oxygen content was 2.5 times that of 
cells without ORM treatment (Fig. 2, B and C). To determine whether 
the elevated intracellular oxygen content promoted cellular energy 
production, we measured the intracellular adenosine triphosphate 
(ATP) level in HaCaT cells. The ATP level in the group treated with 
ORMs was significantly increased over that in the group without 
ORM treatment (P < 0.01; Fig. 2D), demonstrating that increased 
cell survival and migration by continuous oxygenation is associated 
with increased intracellular oxygen content and energy generation.
Oxygen-mediated wound healing is associated with various 
signaling molecules or pathways, such as mitogen-activated protein 
kinase (MAPK) (9), transforming growth factor–1 (38), heme 
oxygenase 1 (HO-1) (39), and heat shock proteins (40). Many 
researchers have confirmed that HBOT activates MAPK pathway, 
which modulates cellular responses such as proliferation and migra-
tion (9). Thus, we investigated whether the ORMs can increase 
MAPK activity to promote the survival and migration of skin cells. 
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Fig. 1. ORMs continuously release oxygen and regulate skin cell behaviors in vitro. (A) Schematic illustration of ORMs and its oxygen-release mechanism. (B) Scanning 
electron microscopy image of ORM. (C) Fluorescent image of ORM. (D) Fluorescent image of ORM after catalase (labeled with FITC) conjugation. Color of FITC was adjusted. 
(E) Oxygen-release kinetics of ORMs. n = 8. (F to H) Double-stranded DNA (dsDNA) content of HaCaT cells (n = 5) (F), human dermal fibroblasts (HDFs; n = 5) (G), and human 
arterial endothelial cell (HAECs; n = 3) (H) cultured under hypoxia. (I to K) ROS content in HaCaT cells (n = 10) (I), HDFs (n = 6) (J), and HAECs (n = 8) (K) cultured under 
normoxia, hypoxia, or hypoxia with ORM. (L and M) Migration of HaCaT cells cultured under hypoxia. n = 4. (N) Gene expression of PDGFB, VEGFA, and FGF2 in HaCaT cells 
cultured under hypoxia. n ≥ 3. (O and P) Migration of HDFs cultured under hypoxia. n = 4. (Q) Gene expression of PDGFB, VEGFA, and FGF2 in HDFs cultured under hypoxia. 
n ≥ 3. (R) Schematic illustration of HAEC tube formation assay. (S and T) Tube formation (S) and tube density (T) of HAECs cultured under hypoxia for 16 hours. Scale bars, 
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whether the extracellular signal–regulated kinase (Erk1/2) axis, one of 
the major cascades of the MAPK pathway, was activated in response to 
the released oxygen. The results demonstrated that Erk1/2 phosphoryl-
ation was increased after the cells were treated with ORMs under 
1% oxygen (Fig. 2E). In addition, we investigated whether HO-1, a 
stress-inducible and cytoprotective protein, was up-regulated after 
treatment with released oxygen under hypoxia. In the ORM group, 
the HO-1 expression was more pronounced than in the control 
group (Fig. 2E). Together, the above results reveal that continuous 
oxygenation by released oxygen activated the Erk1/2 and HO-1 
pathway, leading to enhanced cell survival and migration.
The injectable, thermosensitive, and ROS-scavenging 
hydrogel delivered ORMs and protected skin cells  
under oxidative stress
To deliver the ORMs to diabetic wounds and largely retain them in 
the tissue, we synthesized an injectable and thermosensitive hydrogel 
with a fast gelation rate. The hydrogel was also designed to capture 
up-regulated ROS in diabetic wounds to protect skin cells from 
ROS-induced apoptosis. This hydrogel may also eliminate ROS 
generated by excessive oxygen release. The hydrogel was synthesized 
by copolymerizing NIPAAm, HEMA, and 4-(acryloyloxymethyl)- 
phenylboronic acid pinacol ester (Fig. 3, A and B, and fig. S5). The 
hydrogel solution [6 weight % (wt%)] had a gelation temperature of 
17°C, and it was injectable at 4°C. After being transferred into a 
37°C water bath, the hydrogel solution solidified within 6 s (Fig. 3C). 
The mixture of hydrogel solution and ORMs (40 mg/ml) remained 
injectable at 4°C and gelled quickly (6 s) at 37°C (Fig. 3C).
The ROS-scavenging capability of the hydrogel was evaluated in 
terms of its consumption of hydroxyl radical (HO•) and superoxide 
(O2•−) and by the hydrogel weight loss induced by H2O2. After 
incubation with HO• for 1 day, the hydrogel scavenged markedly more 
HO• than the non–ROS-responsive control hydrogel (P < 0.001; 
Fig. 3D). Similarly, the hydrogel eliminated eightfold more O2•− than 
the control hydrogel after incubation for 1 day (P < 0.001; Fig. 3E). 
The hydrogel gradually lost weight in H2O2 solution during the 
4-week experimental period (Fig. 3F). In contrast, the hydrogel did 
not show substantial weight loss in Dulbecco’s phosphate-buffered 
saline (DPBS) without H2O2.
To evaluate the efficacy of the hydrogel in protecting skin cell 
survival under pathological oxidative stress, HaCaT cells were seeded 
on the hydrogel surface in the presence of 100 M H2O2, and the 
cell viability was quantified (Fig. 3G). The non–ROS-responsive 
hydrogel was used as a control. We found that HaCaT cells seeded 
on the hydrogel did not undergo substantial apoptosis in 100 M 
H2O2 at 48 hours and even proliferated at 72 hours. However, HaCaT 
cells on the non–ROS-responsive hydrogel had significantly lower 
viability than the ROS-responsive hydrogel (P < 0.001 at 48 and 
72 hours), with only ~50% viability at 72 hours (Fig. 3H). These 
results demonstrate that the ROS-responsive hydrogel was able to 
protect keratinocytes from apoptosis caused by pathological oxida-
tive stress.
Diabetic wound closure was accelerated by continuous 
oxygenation and ROS scavenging
To determine whether continuous oxygenation and ROS scavenging 
can accelerate diabetic wound healing, we administered the hydro-
gel with ORMs (Gel/ORM group) onto full-thickness excisional 
wounds on diabetic mice (Fig. 4A). Wounds without treatment (No 
treatment group) and wounds treated with hydrogel alone (Gel 
group) were used as controls. The wounds treated with Gel/ORM 
had a greater closure rate than the No treatment and Gel groups 
(Fig. 4B). By day 16, the wound size in the Gel/ORM group was 
reduced to 10.7%, significantly smaller than that in the Gel (30.4%) 
and No treatment groups (52.2%) (P < 0.01; Fig. 4C). Notably, the 
wound size in the Gel group was substantially smaller than in the 
No treatment group, demonstrating that the Gel alone promoted 
wound closure.
Fig. 2. ORMs elevate intracellular oxygen content and ATP content and activate HO-1 and Erk1/2 pathways under hypoxia. (A to C) Intracellular oxygen content 
measured by EPR. Keratinocytes (HaCaT cells) were incubated with lithium phthalocyanine (LiPc) nanoparticles for endocytosis and then cultured under 1% oxygen conditions 
(with or without ORM) for 24 hours. n = 3 for each group. *P < 0.05. (D) Intracellular ATP content in HaCaT cells measured by an ATP assay kit. Cells were cultured under 1% 
oxygen conditions (with or without ORM) for 24 hours. **P < 0.01. (E) Immunoblotting of HO-1 and phosphorylated Erk1/2 (p-Erk1/2) in dermal fibroblasts cultured under 
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Reepithelialization is crucial in wound healing. To evaluate 
the rate of reepithelialization, we used cytokeratin 14 (K14) and 
cytokeratin 10 (K10), two markers for basal keratinocytes and spinous 
keratinocytes, respectively, to stain tissue sections harvested on 
days 8 and 16. On day 8, in the Gel/ORM group, the wound gap was 
nearly enclosed by a complete layer of basal keratinocytes (K14+), 
while in the No treatment and Gel groups, keratinocyte migration 
was much slower (Fig. 4D and fig. S6). In addition, compared to the 
No treatment and Gel groups, the Gel/ORM group formed a more 
mature spinous layer composed of K10+ keratinocytes. On day 16, 
the migration of basal keratinocytes was complete, and proliferation 
and differentiation were ongoing in the No treatment and Gel groups. 
In contrast, reepithelialization was fully complete in the Gel/ORM 
group, as evidenced by a clear stratified epithelium (Fig. 4D and fig. 
S6). On both day 8 and day 16, K14 staining of the hair follicles in 
the basal layer of the epidermis (Fig. 4E) revealed a significantly 
increased hair follicle density in the Gel/ORM group than in the No 
treatment and Gel groups (P < 0.01; Fig. 4F). These results demon-
strate that the continuous oxygenation by released oxygen, together 
with ROS scavenging, effectively accelerated keratinocyte migration 
and hair follicle formation, consequently promoting reepithelialization 
of the diabetic wounds.
Epidermal thickness, another indicator of wound healing, increases 
during the initial inflammatory and proliferative stages and then 
decreases during the remodeling stage (41). On day 8, the wounds 
treated with Gel/ORM exhibited the thickest epidermis. By day 16, 
it had become the thinnest (P < 0.001; Fig. 4, G and H), suggesting 
that the continuous oxygenation and ROS scavenging facilitated the 
wound’s healing progressions from the inflammatory and proliferative 
stages to the remodeling stage.
To determine whether the accelerated wound closure was 
associated with scar formation, we performed picrosirius red staining 
for collagens in the wounds. On day 16, the Gel/ORM group had a 
significantly lower total collagen content than the No treatment 
Fig. 3. ROS-scavenging hydrogel protects skin cells under oxidative stress by consuming hydroxyl radicals and superoxides. (A) ROS-scavenging (ROSS) hydrogel 
capable of scavenging ROS in chronic wounds or generated from released oxygen or PVP/H2O2. (B) Synthesis and ROS-scavenging mechanism of ROSS hydrogel. BPO, 
benzoyl peroxide. (C) Injectability and gelation of ROSS hydrogel (Gel) and Gel/ORM construct. (D) Scavenging effect on hydroxyl radicals of ROSS gel and non–ROS- 
responsive gel (Control) (n = 4). (E) Scavenging effect on superoxide of ROSS gel and non–ROS-responsive gel (Control) (n = 3). (F) Degradation of ROSS gel at 37°C for 
4 weeks in DPBS with 0 and 50 mM H2O2. (G) Schematic illustration of an in vitro model for skin cell survival on gels under 100 M H2O2 to mimic the in vivo cell environment 
under oxidative stress. Non–ROS-responsive gel was used as a control. (H) Cell viability of HaCaT cells at 48 and 72 hours on control gel and ROSS gel (normalized to the 
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group (P < 0.05; Fig. 4, I and J). In addition, a significantly higher 
collagen I/III ratio was found for the Gel/ORM group than the No 
treatment and Gel groups (P < 0.05; Fig. 4K). Compared to the 
control groups, this collagen I/III ratio was closer to that of unin-
jured skin. The reduced collagen deposition and higher collagen I/III 
ratio demonstrate that the enhanced wound healing did not induce 
scar formation (42, 43).
Continuous oxygenation and ROS scavenging in diabetic 
wounds promoted cell proliferation and metabolism
To understand the role of continuous oxygenation and ROS scaveng-
ing in diabetic wound healing at the cellular level, we examined cell 
proliferation and metabolism in the wounds. Compared to the No 
treatment group on both day 8 and day 16, the ROS-scavenging ac-
tivity of the hydrogel alone had significantly increased the density 
of Ki67+ proliferating cells. On day 16, the density of proliferating 
cells treated with Gel/ORM had increased further (Fig. 5, A and C). 
Continuous oxygenation and ROS scavenging also increased the 
skin cell metabolic rate, as judged by the peroxisome proliferator–
activated receptor gamma coactivator 1  (PGC1) positive cell 
density (Fig.  5,  B  and  D) (44). Compared with the No treatment 
group, the Gel group exhibited a significantly higher density of 
PGC1+ cells. The release of oxygen in the Gel/ORM group further 
increased the PGC1+ cell density at both time points.
Continuous oxygenation and ROS scavenging in diabetic 
wounds stimulated angiogenic growth factor expression 
and angiogenesis
To determine whether continuous oxygenation and ROS scaveng-
ing affect the expression of angiogenic growth factors in diabetic 
wounds, real-time reverse transcription polymerase chain reaction 
(RT-PCR) was performed using wound tissues extracted 8 days 
after surgical wounding (Fig. 5, E and F). Among different angio-
genic growth factors, Pdgfb expression was significantly increased 
in both the Gel and Gel/ORM groups (P < 0.01; Fig. 5E), with the 
Gel/ORM group showing substantially greater expression than the 
Gel group (P > 0.05). Notably, the Gel/ORM group exhibited sig-
nificantly higher Vegfa expression than the Gel and No treatment 
groups (P < 0.01; Fig. 5F).
To evaluate whether continuous oxygenation and ROS scaveng-
ing stimulated angiogenesis in the diabetic wounds, we quantified 
the capillary densities in the Gel/ORM, Gel, and No treatment 
groups at middle stage (day 8) and late stage (day 16) of the wound 
healing. At both stages, the Gel group had a significantly higher density 
of capillaries than the No treatment group, demonstrating that ROS 
scavenging promoted diabetic wound angiogenesis (Fig. 5, G and H). 
The simultaneous ROS scavenging and continuous oxygenation in 
the Gel/ORM group further significantly stimulated angiogenesis 
(Fig. 5, G and H).
Continuous oxygenation and ROS scavenging in diabetic 
wounds alleviated oxidative stress, inflammation, 
and proinflammatory cytokine expression
The ROS-scavenging hydrogel decreased the ROS content in diabetic 
wounds (Fig. 6, A and C). On both day 8 and day 16, the ROS+ cell 
density was markedly lower in the Gel group than in the No treat-
ment group (P < 0.001). Although the continuous oxygenation of the 
diabetic wounds may have led to the formation of ROS, the hydrogel 
was able to capture it. On days 8 and 16, the Gel and Gel/ORM 
Fig. 4. ORMs encapsulated in ROS-scavenging hydrogel accelerate wound 
healing in db/db mice. (A) Schematic illustration of the design of animal experiments 
to test the therapeutic effect of ROSS gel (Gel) and ORMs in a db/db mouse model. 
(B) Representative images of the wounds treated with or without Gel and ORMs for 
16 days. (C) Wound size change during 16 days of post wounding. Wound size at 
each time point was normalized to day 0. n ≥ 8. (D) Immunofluorescence staining 
of cytokeratin 10 (K10, green) and cytokeratin 14 (K14, red) for the wounds at days 8 
and 16. Scale bars, 200 m. (E) Immunofluorescence staining of K14 (red) in the 
wounded region at days 8 and 16. Scale bars, 50 m. (F) Quantification of hair follicle 
density in the wounded region at days 8 and 16. (G) Hematoxylin and eosin staining 
of the wounded skin at days 8 and 16. Scale bars, 500 m. (H) Quantification of 
epidermal thickness. Epidermal thickness was calculated in the region where wound 
was closed. (I) Picrosirius red staining of the wounded skin at day 16. Scale bar, 50 m. 
(J) Quantification of total collagen deposition at day 16. (K) Quantification of collagen I/III 
ratio at day 16. *P < 0.05, **P < 0.01, and ***P < 0.001. Photo credit: Ya Guan and 
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groups showed similar densities of ROS+ cells (P  >  0.05; Fig.  6, 
A and C), demonstrating that the hydrogel can efficiently scavenge 
ROS even if continuous oxygenation induces ROS formation.
To elucidate the impact of continuous oxygenation and ROS 
scavenging on the inflammatory response in diabetic wounds, we 
evaluated inflammatory cell density in the tissue by CD86 staining. 
The CD86+ inflammatory cell density in the Gel and Gel/ORM 
groups was significantly lower than in the No treatment group 
(with P < 0.001 on day 8 and P < 0.05 on day 16; Fig. 6, B and D). 
Notably, the Gel and Gel/ORM groups had similar inflammatory 
cell densities. These results demonstrate that ROS scavenging by the 
hydrogel decreased diabetic wound inflammation.
To further reveal the role of released oxygen in tissue inflamma-
tion, we assessed proinflammatory cytokine expressions in diabetic 
wounds (Fig. 6, E and F). Compared with the Gel group, the Gel/ORM 
group exhibited reduced expression of various proinflammatory 
Fig. 5. Continuous oxygenation and ROS scavenging promote cell proliferation and metabolism and stimulate angiogenic growth factor expression and angio-
genesis in diabetic wounds. (A) Immunofluorescence staining of Ki67 (red) in the wounded region at 8 and 16 days after wounding. Scale bars, 50 m. (B) Immunofluo-
rescence staining of PGC1 (green) in the wounded region at 8 and 16 days after wounding. Scale bars, 50 m. (C) Quantification of Ki67+ cell density. (D) Quantification 
of PGC1+ cell density. (E and F) Gene expression of Pdgfb (E) and Vegfa (F) from the tissue lysates extracted from the wounded skin at day 8. n ≥ 4. (G) Immunofluores-
cence staining of isolectin (green) in the wounded region at 8 and 16 days after wounding. Scale bars, 50 m. Nuclei were stained with DAPI in all immunofluorescence 
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cytokines, such as interleukin-1 (IL-1), tumor necrosis factor– 
(TNF-), interferon- (IFN-), and chemokine ligand 1(CXCL1). 
These results suggest that continuous oxygenation has the potential 
to decrease inflammation during diabetic wound healing.
Continuous oxygenation in diabetic wounds up-regulated 
phosphorylated Erk1/2 and HO-1 expressions
After showing that the oxygenation of keratinocytes by released 
oxygen up-regulated phosphorylated Erk1/2 (p-Erk1/2) and HO-1 
expressions in vitro, we next evaluated whether continuous oxy-
genation up-regulated these expressions in diabetic wounds. Consist-
ent with the in vitro findings, the p-Erk1/2 and HO-1 expressions 
were substantially up-regulated in the Gel/ORM group on days 8 
and 16 (Fig. 7).
DISCUSSION
Chronic hypoxia is a main characteristic of diabetic wounds and a 
severe impediment to the healing process. Consequently, sustained 
oxygenation of skin cells to mitigate chronic hypoxia represents an 
approach to accelerating diabetic wound healing. Oxygen therapy is 
advantageous over drug therapy because it raises fewer toxicity con-
cerns (45). However, current oxygen therapy approaches cannot 
provide sufficient oxygen to metabolic-demanding skin cells long 
enough to promote diabetic wound healing (46–48). In this work, 
we developed an oxygen-release system that continuously oxygenates 
diabetic wounds. It is composed of ORMs and their carrier, an 
injectable, thermosensitive, fast-gelling, and ROS-scavenging hydrogel. 
The ORMs have a core-shell structure, with PVP/H2O2 complex as 
the core and a bioeliminable polymer as the shell. The high–molecular 
Fig. 6. Continuous oxygenation and ROS scavenging alleviate oxidative stress, inflammation, and proinflammatory cytokine expression in diabetic wounds. 
(A) Immunofluorescence staining of CM-H2DCFDA (red) at the wounded site at days 8 and 16. Scale bars, 50 m. (B) Immunofluorescence staining of CD86 (red) at the 
wounded site at days 8 and 16. Scale bars, 50 m. Nuclei were stained with DAPI in all immunofluorescence staining images. (C) Quantification of ROS+ cell density. The 
results were normalized to the ROS+ cell density in No treatment group at day 8. n ≥ 8. (D) Quantification of CD86+ cell density. *P < 0.05 and ***P < 0.001. (E) Cytokine 
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weight PVP/H2O2 complex reduces H2O2 diffusivity, allowing for 
sustained release of H2O2 during the hydrolysis of the shell polymer 
(49, 50). The ORM surface is conjugated with catalase to timely 
convert H2O2 in the released PVP/H2O2 into molecular oxygen 
(Fig. 1A). Therefore, the ORMs can directly release oxygen (Fig. 1E), 
whereas most other oxygen-release systems directly release H2O2 
instead of oxygen (20, 51, 52). We demonstrated that the microspheres 
could release oxygen for at least 2 weeks (Fig. 1E), longer than most 
other oxygen-release systems (20, 22). The injectable, thermosensitive, 
and fast-gelling hydrogel used as the ORM carrier largely retained 
the ORMs in the diabetic wounds after delivery. The ROS-scavenging 
hydrogel both eliminates the H2O2 in the released PVP/H2O2, even 
if it is not completely converted by catalase, and captures the 
up-regulated H2O2 in diabetic wounds to decrease oxidative stress 
and accelerate wound healing. To the best of our knowledge, no 
current oxygen-release system has been designed to release molecular 
oxygen and scavenge ROS simultaneously.
We evaluated the efficacy and mechanism of action of the 
oxygen-release system in healing excisional wounds in db/db mice 
(Fig. 4A). This model exhibits significant delay in wound closure and 
impaired wound bed vascularization compared with other well- accepted 
murine diabetes models, such as streptozocin-induced C57BL/6J 
and Akita mice (53). Our results showed that the oxygen-release 
system substantially promoted wound closure (Fig. 4C). More 
specifically, we sought to demonstrate that the accelerated wound 
healing was caused by the sustained oxygenation and ROS scavenging 
in diabetic wounds that augmented cell survival, accelerated cell 
migration, stimulated angiogenesis, and reduced oxidative stress 
and inflammation (Fig. 8).
First, we investigated the effect of oxygen released from ORMs 
on skin cell survival in a hypoxic environment. We conducted in vitro 
studies under 1% O2 and high-glucose conditions to mimic the 
in vivo microenvironment in diabetic wounds (8, 54). The survival 
of keratinocytes, fibroblasts, and endothelial cells under hypoxia 
was significantly increased with the supplement of oxygen released 
from the ORMs (Fig. 1, F to H). These three cell types are responsible 
for epithelialization, wound contraction, and angiogenesis. In dia-
betic wounds, treatment with the oxygen-release system significantly 
increased the density of proliferating cells (Fig.  5,  A  and  C). The 
augmented cell survival can be attributed to the elevated cellular 
oxygen content (Fig. 2C). Cellular oxygen is essential for mitochondrial 
metabolism, and the low oxygen level in diabetic wounds impairs 
this process (55). The release of oxygen significantly increased the 
mitochondrial metabolism of the cells in the wounds on day 8, as 
evidenced by greater PGC1+ cell density (Fig. 5, B and D). Mecha-
nistically, we found that the enhanced skin cell survival with released 
oxygen is associated with the up-regulation of p-Erk1/2 in vitro and 
in vivo (Figs. 2E and 7).
Next, we demonstrated that continuous oxygenation of skin cells 
promoted the migration and paracrine effects of keratinocytes and 
fibroblasts under hypoxia (Fig. 1, L to Q). The migration of these 
cells is essential for the regeneration of the epidermis and dermis. 
The enhanced paracrine effects, in terms of up-regulation of growth 
factors such as VEGFA, FGF2, and PDGFB, facilitate the regenera-
tion. Specifically, VEGFA and FGF2 have been found to increase 
keratinocyte migration and proliferation (56–59). The up-regulated 
expression of VEGFA, FGF2, and PDGFB in skin cells in response to 
released oxygen may be attributed to increased p-Erk1/2 expression 
(Fig.  2E). Previous studies have demonstrated that activation of 
Erk1/2 pathway was able to up-regulate cell angiogenic growth factor 
expression (60–62). The enhanced keratinocyte survival, migration, 
and paracrine effects of continuous oxygenation led to a significant 
increase in the wound closure rate (Fig.  4C) and formation of a 
stratified epithelium (Fig. 4D).
Angiogenesis in diabetic wounds is essential for the regeneration 
of the dermis. Although acute hypoxia induces angiogenesis mediated 
by hypoxia-inducible transcription factors, chronic oxygen depri-
vation cannot sustain this process, thereby impairing the healing 
process (6). We found that the released oxygen increased endothelial 
cell survival (Fig. 1H) and tube formation (Fig. 1, R to T) in vitro. In 
diabetic wounds, the continuous oxygenation significantly stimu-
lated capillary formation (Fig. 5, G and H). The quicker angiogenesis 
may also be attributed to the enhanced paracrine effects because the 
expressions of angiogenic growth factors Pdgfb and Vegfa were 
substantially up-regulated (Fig. 5, E and F).
Furthermore, we showed that the developed oxygen delivery system 
alleviated oxidative stress in diabetic wounds (Fig. 6, A and C). The 
decreased oxidative stress was due to the ROS-scavenging hydrogel 
since the ROS+ cell densities in the Gel and Gel/ORM groups were 
similar. This result minimizes potential concern that oxygen release 
may lead to ROS overproduction. The decreased oxidative stress 
may also be associated with increased HO-1 expression under 
hypoxic conditions (Figs. 2E and 7). HO-1 has antioxidant effects 
and has been reported to promote diabetic wound healing (63, 64).
Last, we showed that the oxygen-release system reduced inflam-
mation in diabetic wounds (Fig. 6, B and D). Chronic wounds are 
characterized by a high concentration of proinflammatory cells, the 
major contributor of proinflammatory cytokines, such as TNF-, 
IL-1, and CXCL1 (65). In addition, hyperglycemia exacerbates 
inflammatory stress via the production of proinflammatory cytokines 
such as TNF- (66). Our results show that ROS-scavenging hydrogel 
greatly decreased the number of inflammatory cells (Fig. 6, B and D) 
and the released oxygen further reduced the expression of major 
proinflammatory cytokines (Fig. 6, E and F). Future studies will 
focus on delineating signaling pathways as the underlying mecha-
nism in suppressing inflammation by sustained oxygen release in 
diabetic wounds.
Overall, we demonstrate in this report that a sustained oxygen- 
release system that simultaneously scavenges ROS substantially 
accelerated diabetic wound closure. The sustained release of oxygen had 
multiple effects: It promoted skin cell survival, migration, and paracrine 
effects; stimulated endothelial tube formation and angiogenesis; 
Fig. 7. ORMs activate HO-1 and Erk1/2 pathways. Immunoblotting of HO-1 and 
p-Erk1/2 from the tissue lysates extracted from wounded skin at days 8 and 16 after 
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and decreased tissue inflammation. Compared with the results of 
previous studies using growth factors or exogenous cells to treat 
impaired wound healing in the same animal model, our oxygen- 
release system exhibited faster (67–69) or similar wound closure 
rates (70, 71). Thus, it represents an effective therapeutic approach 
for accelerated healing of chronic diabetic wounds without using 
drugs. Beyond wound healing, the developed oxygen-release system 
may be used to treat other ischemic diseases, such as peripheral 
artery disease and coronary heart disease. Given the limitations of 
rodent models in illustrating more complex human pathophysiology, 
we will further test our oxygen-release system in large animals 




All chemicals were purchased from MilliporeSigma unless otherwise 
stated. NIPAAm (TCI) was recrystallized in hexane before use. 
HEMA (Alfa Aesar) was used before passing through a column 
filled with inhibitor removers. Benzoyl peroxide (BPO; Thermo 
Fisher Scientific), acryloyl chloride, 4-(hydroxymethyl)-phenylboronic 
acid pinacol ester, triethylamine (Fisher Scientific), PVP (40 kDa; 
Fisher Scientific), hydrogen peroxide solution (30%), and bovine 
liver catalase (2000 to 5000 U/mg) were used as received.
Synthesis and characterization of ROS-scavenging hydrogel
4-(acryloxymethyl)-phenylboronic acid pinacol ester was synthesized 
by the reaction between acryloyl chloride and 4-(hydroxymethyl)- 
phenylboronic acid pinacol ester (72). The ROS-scavenging hydrogel 
was synthesized by free radical polymerization of NIPAAm, HEMA, 
and 4-(acryloxymethyl)-phenylboronic acid pinacol ester using BPO 
as initiator and 1,4-dioxane as solvent. The reaction was conducted 
at 70°C overnight with the protection of nitrogen. The polymer 
solution was precipitated in hexane. The polymer was purified twice 
by dissolving in tetrahydrofuran and precipitating in ethyl ether. 
The polymer was dissolved in DPBS at 4°C to make a 6 wt% solution. 
The injectability of the 4°C solution with or without ORMs (40 mg/ml) 
was tested by a 26-gauge needle (73, 74).
Hydrogel H2O2 responsiveness was characterized by its weight 
loss after being incubated in H2O2 solution for 4 weeks. Briefly, the 
hydrogel solution was solidified in 1.5 ml microcentrifuge tubes at 
37°C. After the supernatant was discarded, 0.2 ml, 37°C DPBS with 
or without 50 mM H2O2 was added. The samples were collected at 
predetermined time points and freeze-dried. The weight loss was 
calculated. To determine scavenging capability of the hydrogel for 
hydroxyl radicals and superoxide, Fenton reaction assay (75) and 
pyrogallol assay (76) were performed, respectively. Briefly, for Fenton 
reaction assay, hydrogel solution or deionized (DI) water (control 
group) was incubated with FeSO4, safranin O, and H2O2 for 5 min, 
followed by heating at 55°C for 30 min. After the samples were 
cooled to room temperature, the absorbance was measured at 
492 nm using a microplate reader. For pyrogallol assay, the hydrogel 
solution or DI water was mixed with tris-HCl. Pyrogallol solution 
(3 mM) was then added dropwise in the dark. The reaction was 
terminated by adding 8  M HCl. The absorbance was acquired 
at 299 nm.
Cell survival on ROS-scavenging hydrogel 
in the presence of H2O2
The ROS-scavenging hydrogel was plated on 96-well plates. HaCaT 
cells (AddexBio) were seeded on the hydrogel surface at a density of 
50,000 per well in optimized Dulbecco’s modified Eagle’s medium 
(DMEM, AddexBio) with 5% fetal bovine serum (FBS) and 1% 
penicillin-streptomycin. After 24 hours of culture, the medium was 
discarded. A total of 200 l of 100 M H2O2-containing medium 
was added to each well. At 48 and 72 hours, the viability of HaCaT 
was measured by MTT assay. The non–ROS-responsive hydrogel, 
Fig. 8. Mechanisms of accelerated wound healing by ORMs encapsulated in ROS-scavenging hydrogel. The ORMs and ROSS gel augmented cell proliferation and 
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poly(NIPAAm-co-HEMA-co-acrylate-oligolactide), was used as a 
control (50, 74).
Fabrication of ORMs and catalase conjugation
The ORMs were fabricated by double emulsion method. Briefly, the 
shell of the microspheres was synthesized by the copolymerization 
of NIPAAm, HEMA, NAS, and AOLA. The chemical structure of the 
shell polymer was confirmed by 1H-NMR (proton nuclear magnetic 
resonance) (fig. S1). The synthesized polymer was dissolved in 
dichloromethane to form the 5 wt% oil phase. The inner water phase 
was prepared by dissolving 242 mg of PVP in 1 ml, 30% H2O2 at 
4°C overnight. The water phase was rapidly added into the oil phase 
and sonicated by an ultrasonic liquid processor (Cole Parmer). The 
primary water-in-oil emulsion was then poured into poly(vinyl 
alcohol) solution to form the water- in-oil-in-water double emulsion. 
The mixture was stirred for 3 hours to remove dichloromethane, fol-
lowed by centrifugation to collect the microspheres. Morphology and 
size of the microspheres were characterized by scanning electron 
microscopy images. To confirm the core-shell structure, FITC and 
rhodamine were added to the PVP/H2O2 solution and polymer/
dichloromethane solution, respectively. The fluorescent images were 
acquired by a confocal microscope. To conjugate catalase onto the 
microsphere shell, 40 mg microspheres were mixed with 6 ml catalase 
solution (5 mg/ml in DI water) and stirred for 4 hours at 4°C. The 
mixture was then centrifuged. The microspheres were washed three 
times with DI water to remove unconjugated catalase. To confirm 
the conjugation, the catalase was prelabeled by FITC, and the fluo-
rescent images of the microspheres were taken after the conjugation.
Oxygen-release kinetics
The ROS-sensitive hydrogel was dissolved in 4°C DPBS to make a 
6 wt% solution. The ORMs were then mixed with the hydrogel solu-
tion at a concentration of 40 mg/ml. The oxygen-release kinetics 
was determined by our established method (50, 74, 77). The wells of 
a 96-well plate were covered by a polydimethylsiloxane membrane 
loaded with an oxygen-sensitive luminophore Ru(Ph2phen3)Cl2 
and an oxygen-insensitive dye rhodamine B. Two hundred microliters 
of the mixture was then added into each well (n = 8 for each group). 
After gelation at 37°C, the supernatant was removed. A total of 
200 l of DPBS preincubated in 1% oxygen condition was added. The 
oxygen-release study was performed in 1% oxygen and 37°C condi-
tions for 2 weeks. At each time point, the fluorescent intensity for 
Ru(Ph2phen3)Cl2 was measured (emission at 610 nm and excitation 
at 470 nm). The fluorescent intensity for rhodamine was also deter-
mined (emission at 576 nm and excitation at 543 nm) and used for 
normalization. Oxygen concentration was determined by the cali-
bration curve.
Cell survival, migration, and ROS content under hypoxia
HaCaT cells (AddexBio) were cultured in optimized DMEM 
(AddexBio) with 5% FBS and 1% penicillin-streptomycin. HDF (Lonza) 
were cultured in FGM-2 BulletKit (Lonza). HAEC (Cell Systems) 
were cultured in EGM-2 BulletKit (Lonza). The medium was changed 
every other day.
For all in vitro studies, cells were cultured using high-glucose 
(450 mg/dl) and serum-free medium under 1% oxygen and 37°C 
conditions. To determine cell survival, the cells were cultured in a 
96-well plate using medium with or without ORMs (40 mg/ml, 
n ≥ 5 for each group). The dsDNA content was measured using 
PicoGreen dsDNA assay kit (Invitrogen) after 5 days of culture for 
HaCaT cells and HDFs and after 7 days of culture for HAEC.
To perform cell migration assay, the cells were first cultured in a 
six-well plate to reach 85 to 95% confluency (n = 4 for each group). 
The monolayer was then scraped with a 200 l pipette tip, washed, 
and supplemented with serum-free medium with or without ORMs 
(40 mg/ml). After 48 hours, optical images were taken using an 
optical microscope (Olympus IX70). The distances between two 
sides of the scratch were measured using ImageJ. The migration 
ratio was calculated as
  migration ratio =  Interval at 0 hour − interval at 48 hours   ───────────────────────  Interval at 0 hour × 100% 
To measure intracellular ROS content, the cells were prestained 
with ROS-sensitive dye CM-H2DCFDA and cultured with serum- 
free medium with or without ORMs (40 mg/ml). After 3 days of 
culture for HaCaT cells and HAEC and 5 days of culture for HDF, 
the cells were fixed and stained with 4′,6-diamidino-2-phenylindole 
(DAPI). Fluorescent images were taken using a confocal micro-
scope. The CM-H2DCFDA positive cell density was quantified 
from at least 10 images for each group and then normalized to the 
CM-H2DCFDA positive cell density cultured under normoxia.
Measurement of intracellular oxygen content
To determine the intracellular oxygen content, HaCaT cells were 
incubated with lithium phthalocyanine nanoparticles for 2 hours to 
allow cellular uptake. The residual nanoparticles were washed with 
DPBS three times. After trypsinization, the cells were encapsulated 
in the ROS-sensitive hydrogel or mixture of hydrogel and ORMs 
(40 mg/ml). The samples were transferred into EPR tubes (Wilmad- 
LabGlass, n = 3 for each group). The EPR tubes were opened on 
both sides and placed in a hypoxic incubator (1% oxygen, 37°C) for 
4 hours for complete gelation and gas balance. After that, the tubes 
were sealed and incubated for 24 hours under 1% oxygen. The EPR 
spectrum was recorded using an X-band EPR instrument (Bruker). 
The parameters used in this experiment were 0.1 mW for micro-
wave power, 1.0 dB for attenuation, and 9.8 GHz for frequency, 
following our reported method (77, 78). Oxygen partial pressure (pO2) 
was calculated from the linewidth of the spectrum and calibration 
curve of linewidth versus oxygen concentration.
Measurement of intracellular ATP level
To determine the intracellular ATP level, HaCaT were cultured in a 
six-well plate to reach 85 to 95% confluency. The culture medium 
was then replaced with serum-free media with or without ORMs 
(40 mg/ml). After 24-hour incubation under 1% O2, the cells were 
lysed, and the ATP content was measured by an ATP assay kit as per 
the manufacturer’s instruction (n = 3; MilliporeSigma).
Endothelial tube formation
HAECs were cultured in a 3D collagen model described previously 
(28). Briefly, the model was prepared by mixing rat tail collagen 
type I (Corning), FBS, DMEM, and NaOH. A total of 400 l of the 
mixture was placed in a 48-well plate and incubated at 37°C for 
30 min to allow the formation of jelly-like solid collagen gel. HAECs 
were encapsulated in ROSS gel solution and injected into the collagen- 
based 3D model at a density of 10,000 cells per well. After overnight 











Guan et al., Sci. Adv. 2021; 7 : eabj0153     27 August 2021
S C I E N C E  A D V A N C E S  |  R E S E A R C H  A R T I C L E
12 of 14
stained with DAPI and F-actin. Fluorescent images were taken as 
z-stacks with a confocal microscope (Zeiss LSM 700).
Implantation of hydrogel and ORMs into diabetic wounds
All animal care and experiment procedures were conducted in 
accordance with the National Institutes of Health guidelines. The 
animal protocol was approved by the Institutional Animal Care and 
Use Committee of Washington University in St. Louis. Eight-week 
old, female db/db mice (BKS.Cg-Dock7m +/+ Leprdb/J) were 
purchased from the Jackson laboratory. Blood glucose was measured 
before surgery to ensure that the glucose level was higher than 
300 mg/dl. After anesthetization and removal of hair, two full-thickness, 
5-mm-diameter wounds on the dorsal skin were created for each 
mouse using a biopsy punch. The hydrogel (6 wt% in DPBS) or Gel/ORM 
(6 wt% in DPBS, microspheres at 40 mg/ml) was topically administrat-
ed. Digital images of the wounds (n ≥ 8 for each group) were taken 
every other day, and the wound size was determined using ImageJ. 
After 8 and 16 days of implantation, the mice were euthanized. The wound 
tissues were collected for histological and immunofluorescence 
analysis and RNA and protein isolation.
Histological and immunofluorescence analyses
The wound tissues were fixed in 4% paraformaldehyde overnight, 
embedded in paraffin, and serially sectioned at 5 m. Hematoxylin 
and eosin staining was performed to measure the epidermal thick-
ness in wounded skin. Epidermal thickness was calculated in the 
wound closed region. Picrosirius red staining was used to quantify 
the collagen deposition and collagen I/III ratio. For immunofluo-
rescence analysis, following deparaffinization, antigen retrieval, and 
blocking, the sections were incubated with primary antibodies, 
including rabbit monoclonal anti–cytokeratin 10 (K10; Abcam, ab76318), 
mouse monoclonal anti–cytokeratin 14 (K14; Abcam, ab7800), rabbit 
monoclonal anti-CD86 (Abcam, ab234401), rat monoclonal anti-Ki67 
(Invitrogen, SolA15), isolectin GS-IB4 (Invitrogen, I21411) (79), and 
ROS indicator (CM-H2DCFDA; Invitrogen). The sections were 
then incubated with corresponding secondary antibodies. Nuclei 
were stained with DAPI. Quantification of the stainings was per-
formed using ImageJ. At least six images for each group were used 
for the quantification.
mRNA expression in in vitro cultured cells 
and diabetic wounds
RNA was isolated from the in vitro cultured cells or wound tissues 
using TRIzol following the manufacturer’s instruction. cDNA was 
synthesized using a high-capacity cDNA reverse transcription kit 
(Thermo Fisher Scientific). Gene expression was performed by 
real-time RT-PCR using SYBR Green (Invitrogen) and selected 
primer pairs (table S1). -Actin served as a housekeeping gene. Data 
analysis was performed using the ∆∆Ct method.
Protein expression in in vitro cultured cells 
and diabetic wounds
Protein lysates were collected from the in vitro cultured cells or wound 
tissues and separated by SDS–polyacrylamide gel electrophoresis. 
Low fluorescence polyvinylidene difluoride membranes (Bio-Rad) 
were used to transfer the proteins at 4°C overnight, followed by 
blocking and incubation with primary antibodies at 4°C. The blots 
were washed with PBST (DPBS + 0.1% Tween 20) and incubated with 
appropriate horseradish peroxidase–conjugated secondary antibodies. 
Immunoblots were detected using a detection kit from Advansta 
and imaged using ChemiDoc XRS+ System (Bio-Rad). The primary 
antibodies used were anti–glyceraldehyde-3-phosphate dehydrogenase 
(1:4000; Abcam, ab8245), anti–HO-1 (1:500; Abcam, ab52947), 
anti–p-Erk1/2 (1:500; Cell Signaling Technology, #9101), and anti– 
t-Erk1/2 (1:1000; Cell Signaling Technology, #4695).
For protein array assay, wounded tissue lysates were collected 
and tested using Proteome profiler mouse cytokine array kit 
(R&D Systems) according to the manufacturer’s instructions. The 
pixel density was quantified using Image Lab software (Bio-Rad) (80).
Statistical analysis
All data were presented as means ± SD. Statistical analysis was 
performed between groups using one-way analysis of variance 
(ANOVA) with Tukey’s post hoc test. A value of P < 0.05 was 
considered statistically significant.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/7/35/eabj0153/DC1
View/request a protocol for this paper from Bio-protocol.
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